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Abstract
Background: Results of previous autopsy studies indicate that increased hepatic iron stores or
hepatic iron overload is common in African Americans dying in hospitals, but there are no reports
of hepatic iron content in other cohorts of African Americans.
Methods: We investigated the prevalence of heavy liver iron deposition in African American
adults. Using established histochemical criteria, we graded Perls' acid ferrocyanide-reactive iron in
the hepatocytes and Kupffer cells of 341 consecutive African American adults who were autopsied
in the coroner/medical examiner office. Heavy staining was defined as grade 3 or 4 hepatocyte iron
or grade 3 Kupffer cell iron.
Results: There were 254 men and 85 women (mean age ± 1 SD: 44 ± 13 y vs. 48 ± 14 y,
respectively; p = 0.0255); gender was unstated or unknown in two subjects. Approximately one-
third of subjects died of natural causes. Heavy staining was observed in 10.2% of men and 4.7% of
women. 23 subjects had heavy hepatocyte staining only, six had heavy Kupffer cell staining only, and
one had a mixed pattern of heavy staining. 15 subjects had histories of chronic alcoholism; three
had heavy staining confined to hepatocytes. We analyzed the relationships of three continuous
variables (age at death in years, hepatocyte iron grade, Kupffer cell iron grade) and two categorical
variables (sex, cause of death (natural and non-natural causes)) in all 341 subjects using a correlation
matrix with Bonferroni correction. This revealed two positive correlations: hepatocyte with
Kupffer cell iron grades (p < 0.01), and male sex with hepatocyte iron grade (p < 0.05). We also
analyzed the relationship of steatosis, inflammation, and fibrosis/cirrhosis in 30 subjects with heavy
iron staining using a correlation matrix with Bonferroni correction. There were significant positive
correlations of steatosis with inflammation (r = 0.5641; p < 0.01), and of inflammation with fibrosis/
cirrhosis (r = 0.6124; p < 0.01).
Conclusions: The present results confirm and extend previous observations that heavy liver iron
staining is relatively common in African Americans. The pertinence of these observations to genetic
and acquired causes of iron overload in African Americans is discussed.
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Background
Hepatic iron overload was detected by Perls' acid ferrocy-
anide staining and atomic absorption spectrometry at
autopsy in more than one percent of African American
adults who died in hospitals [1,2]. In one study [1], liver
specimens from 326 unselected adult African Americans
subjects were stained for iron; liver iron was quantified
using atomic absorption spectrometry in subjects in
whom increased stainable iron was observed. Four sub-
jects (1.2%), two men and two women aged 50 to 63
years, had hepatic iron indices adjusted for previous eryth-
rocyte transfusion that were ≥ 1.9 (range 1.9 – 5.6) [1]. In
a second study [2], hepatic iron concentrations of liver tis-
sue from autopsies in 99 African Americans were quanti-
fied. Thirty-one (31.3%) had an elevated hepatic iron
concentration, including nine (9.1%) who had an hepatic
iron concentration greater than twice the upper limit of
normal and no evident cause of secondary iron overload
[2]. These results suggest that iron overload not attributa-
ble to erythrocyte transfusion is relatively common in
African Americans.
In contrast, screening programs that included cohorts of
African Americans presumably representative of the gen-
eral African American population identified a much lower
proportion of subjects with possible iron overload [3-5]
than is suggested by the results of hospital autopsy series
[1,2]. These studies used an elevated transferrin saturation
phenotype criterion generally regarded as the best for
screening whites for HFE-associated hemochromatosis [3-
5]. In these studies, ≤ 0.9% of African Americans adults
had a positive screening result(s), and ≤ 0.09% were sub-
sequently demonstrated to have hemochromatosis or iron
overload [3-5]. Taken together, these observations suggest
that previous reports of increased hepatic iron content in
African Americans dying in hospital may have overesti-
mated the prevalence of non-transfusion iron overload in
African American adults in the general population, or that
the ideal phenotype for screening African Americans for
primary iron overload differs from that which is optimal
for screening whites for HFE-associated
hemochromatosis.
Thus, we graded Perls' acid ferrocyanide-reactive iron in
the livers of 341 consecutive African American adults who
underwent autopsy in the coroner/medical examiner
office. We selected this population for study because such
subjects are more representative of the general African
American population than persons who died in hospital.
We then compared these observations with autopsy
results reported previously in African Americans who died
in hospitals [1,2]. The pertinence of these observations to
genetic and acquired causes of iron overload in African
Americans is discussed.
Methods
Selection of study subjects
The performance of this study was approved by the Insti-
tutional Review Board of the University of Alabama at Bir-
mingham and by the Coroner/Medical Examiner's Office
of Jefferson County, Alabama. We evaluated formalin-
fixed tissue obtained in 361 consecutive, unselected coro-
ner/medical examiner autopsy cases of African-American
adults (age >18 years) in Jefferson County, Alabama;
deaths in all of the present cases occurred during the inter-
val 1998 – 2002. Each subject was identified as African
American by his/her previous medical histories or legal
records, or by the coroner/medical examiner staff. Most
autopsies were performed on the same day that the respec-
tive bodies were available for evaluation at the Coroner/
Medical Examiner's Office; other autopsies were com-
pleted within ~ 18 hours. All tissues were placed directly
in fixative at the time of collection at autopsy. Liver was
not available or was not interpretable due to autolysis in
20 cases. Available records in each case were reviewed; age
at death, sex, summary of known illnesses, and cause of
death were tabulated for all cases for which liver tissue was
available.
Histologic technique, iron grading, and liver morphology
Tissues obtained at autopsy were routinely fixed in 10%
neutral buffered formalin. Triplicate sections of paraffin-
embedded liver were prepared. One section was stained
with hematoxylin and eosin, another with Perls' acid fer-
rocyanide technique to demonstrate non-heme ferric iron
[6], and a third with Masson trichrome technique. Appro-
priate positive and negative control specimens were pre-
pared with each staining batch and reviewed.
All slides were simultaneously reviewed by three investi-
gators, and the iron grades assigned in each case represent
their consensus opinions. Hepatocellular iron was graded
according to these criteria: grade 0 – no visible iron; grade
1 – iron visible in very few hepatocytes; grade 2 – iron vis-
ible in 5 – 10% of hepatocytes; grade 3 – iron visible in ≥
40% of hepatocytes; and grade 4 – abundant iron visible
in most hepatocytes [7]. Kupffer cell iron was graded
according to these criteria: grade 0 – no visible iron in
Kupffer cells; grade 1 – iron visible in ≤ one-third of
Kupffer cells; grade 2 – iron visible in one third to ≤ two-
thirds of Kupffer cells; and grade 3 – abundant iron visible
in more than two-thirds of Kupffer cells [7]. Hepatocyte or
Kupffer cell iron of grades 0 or 1 was defined as normal.
Increased stainable iron was defined as hepatocyte and/or
Kupffer cell iron grade ≥ 2 [7]. Heavy iron staining was
defined as hepatocyte iron grade of 3 or 4, or Kupffer cell
iron grade of 3. Steatosis, inflammation, and fibrosis/cir-
rhosis were assessed as described in detail elsewhere [8];
these abnormalities were graded as absent (0) or present
(+).BMC Clinical Pathology 2005, 5:2 http://www.biomedcentral.com/1472-6890/5/2
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We designated a gradient of stainable iron in hepatocytes
from the periportal area decreasing towards the hepatic
venule as present or absent; visualization of a gradient
required hepatocyte iron staining of grade ≥ 2 [9,10]. The
presence or absence of hepatic cirrhosis was determined
using Masson trichrome-stained specimens as described
previously [8].
Statistical considerations
The present data set consisted of observations in 341 sub-
jects and their respective livers. Analyses were performed
with a computer spreadsheet (Excel 2000®, Microsoft
Corp., Redmond, WA), and a statistical program (GB-Stat®
v. 10.0, 2003, Dynamic Microsystems, Inc., Silver Spring,
MD). Descriptive data are displayed as enumerations, per-
centages, mean ± 1 S.D., medians, and ranges. Frequency
values were compared using chi-square analysis or Fisher
exact test, as appropriate. Mean values were compared
using student t-test. Some data were analyzed using a cor-
relation matrix with Bonferroni correction. Values of p <
0.05 were defined as significant.
Results
General characteristics of study subjects
There were 254 men (mean age 44 ± 13 y; median age 42
y; range 26 – 99 y), and 85 women (mean age 48 ± 14 y;
median age 45 y; range 26 – 89 y). The mean age of men
was lower than that of women (p = 0.0255). There were
two subjects for whom gender was unstated or unknown.
Approximately one-third of subjects died of natural causes
(Table 1).
Liver iron grades
In the 341 evaluable subjects, there was a significant pos-
itive correlation of grades of stainable iron in hepatocytes
and Kupffer cells across the 341 evaluable subjects (Pear-
son r coefficient = 0.2370; p < 0.0001). However, the
mean hepatocyte iron grade was 0.83 ± 0.96; the mean
Kupffer cell iron grade was 0.32 ± 0.32.
Increased hepatocyte iron grades were observed in 64 men
(25.2%) and 8 women (9.4%) (p = 0.0021). Increased
Kupffer cell iron grades were observed in 20 men (7.9%)
and one woman (1.2%) (p = 0.0266) (Tables 2, 3).
Heavy iron staining was observed in 30 subjects (8.8%),
including 10.2% of men and 4.7% of women (p =
0.1202). The mean age of men and women with heavy
iron staining was similar: 45 ± 15 y and 47 ± 9 y (p =
0.7389). 24 subjects (7.1%) had grade 3 or 4 hepatocyte
iron; of these, one also had grade 3 Kupffer cell iron.
Seven subjects (2.1%) had grade 3 Kupffer cell iron; of
these, one also had grade 3 hepatocyte iron. Altogether,
23 subjects had heavy iron staining in hepatocytes only
(Fig. 1), six subjects had heavy iron staining in Kupffer
cells only (Fig. 2), and one subject had a mixed pattern of
heavy hepatocyte and Kupffer cell iron staining (Fig. 3).
The causes of death of the 30 subjects who had heavy iron
staining were similar to those of subjects with lower iron
grades (data not shown).
We analyzed the relationships of three continuous varia-
bles (age at death in years, hepatocyte iron grade, and
Kupffer cell iron grade) and two categorical variables (sex,
cause of death (natural and non-natural causes)) using a
correlation matrix with Bonferroni correction. This
revealed two significant positive correlations: hepatocyte
iron grade with Kupffer cell iron grade (p < 0.01), and
male sex with hepatocyte iron grade (p < 0.05).
Histologic findings in 30 subjects with heavy iron staining
These subjects were comprised of 26 men and 4 women
(Table 3). Hepatic steatosis was observed in eight subjects
(26.7%), hepatic inflammation was observed in 16
Table 1: Causes of death of 341 African Americans autopsied in 
the coroner/medical examiner office.1
Causes of Death Subjects, n Percentage
Homicide 130 38.1
Natural Cause 107 31.4
Accident 90 26.4
Unknown 7 2.1
Suicide 5 1.5
Not Stated 2 0.6
1Chronic alcoholism was listed for 15 subjects (the respective cause 
of death in each subject was ruled to be "natural cause"). Two 
subjects were reported to have diabetes mellitus; one had grade 3 
hepatocyte and grade 1 Kupffer cell iron. No subject was reported to 
have iron overload, hemochromatosis, heritable or acquired forms of 
anemia, or treatment with erythrocyte transfusion.
Table 2: Iron grades of 341 Perls' acid ferrocyanide-stained liver 
sections.1
Grade No. of subjects with 
hepatocyte staining (%)
No. of subjects with Kupffer 
cell staining (%)
0 164 (48.1) 270 (79.2)
1 104 (30.5) 50 (14.7)
2 49 (14.4) 14 (4.1)
3 21 (6.2) 7 (2.1)
4 3 (0.9) not available1
1The present grading system does not include Kupffer cell iron 
staining greater than grade 3. In all subjects, the mean hepatocyte 
grade (± 1 SD) was 0.83 ± 0.96; the mean Kupffer cell grade was 0.32 
± 0.31. A gradient of stainable iron in hepatocytes from the periportal 
area decreasing towards the hepatic venule was observed in 56 
subjects.BMC Clinical Pathology 2005, 5:2 http://www.biomedcentral.com/1472-6890/5/2
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subjects (53.3%), and hepatic fibrosis or cirrhosis was
observed in nine subjects (30.0%). However, 14 subjects
(46.7%) did not have steatosis or inflammation; none of
these 14 subjects had fibrosis/cirrhosis.
We analyzed the relationship of hepatocyte and Kupffer
cell iron grades, steatosis, inflammation, and fibrosis/cir-
rhosis in these 30 subjects (Table 3) using a correlation
matrix with Bonferroni correction. There was a significant
negative correlation of hepatocyte and Kupffer cell iron
grades (r = -0.7368; p < 0.01). There was a significant
positive correlation of steatosis with inflammation (r =
0.5641; p < 0.01). There was a significant positive correla-
tion of inflammation with fibrosis/cirrhosis (r = 0.6124; p
< 0.01).
Subjects with chronic alcoholism
Fifteen subjects had histories of chronic alcoholism; three
of these had heavy liver iron staining. In each case, iron
staining was confined to hepatocytes. The percentage of
subjects with heavy iron staining was similar in 15 sub-
jects reported to have chronic alcoholism and in 326 sub-
jects not reported to have chronic alcoholism (20.0% vs.
8.3%; p = 0.1356).
Three persons who had histories of chronic alcoholism
also had hepatic cirrhosis. A 36 year-old man had grade 0
hepatocyte and grade 0 Kupffer cell iron. A 46 year-old
man had grade 2 hepatocyte iron and grade 0 Kupffer cell
iron. A 50 year-old woman had grade 4 hepatocyte iron
and grade 0 Kupffer cell iron (Fig. 4).
Subjects with cirrhosis
Five subjects had hepatic cirrhosis (1.5%). Three had his-
tories of chronic alcoholism (described above). One of
these three subjects, a 50 year-old woman, had grade 4
Table 3: Histologic findings in 30 African American subjects with heavy liver iron staining1
Age, years Sex Hepatocyte iron 
grade
Kupffer cell iron 
grade
Steatosis Inflammation Fibrosis/cirrhosis
2 6 M 31000
2 7 M 13000
2 8 M 30000
2 9 M 30000
3 0 M 31000
3 4 M 30000
3 4 M 03000
3 7 M32++0
3 7 M31++0
3 9 M 31000
3 9 M 310++
4 0 M23++0
4 2 M 30000
4 3 M 30000
4 4 M 410+0
4 4 M 400++ 2
4 6 M 300+0
4 9 M 30000
5 0 M 130+0
5 2 M30+++
5 5 M 30000
5 9 M30++0
5 9 M 030++
6 3 M31+++
6 7 M 230++
9 1 M30+++ 2
3 3 F33000
5 0 F400++ 2
5 1 F30+++
5 4 F30000
1 Heavy iron staining was defined as hepatocyte iron grade of 3 or 4, or Kupffer cell iron grade of 3. Steatosis, inflammation, and fibrosis/cirrhosis 
were assessed as described in detail elsewhere [8]; these abnormalities were graded as absent (0) or present (+).
2 These subjects had hepatic cirrhosis [8].BMC Clinical Pathology 2005, 5:2 http://www.biomedcentral.com/1472-6890/5/2
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Photomicrograph of non-cirrhotic liver stained with Perls'  technique Figure 1
Photomicrograph of non-cirrhotic liver stained with 
Perls' technique. Liver of a 44 year-old African American 
man who died of pneumonia. There is a predominance of 
iron staining (grade 4) in hepatocytes. Original magnification 
40×.
Photomicrograph of non-cirrhotic liver stained with Perls'  technique Figure 2
Photomicrograph of non-cirrhotic liver stained with 
Perls' technique. Liver of a 34 year-old African American 
man who died of homicide. There is a predominance of iron 
staining (grade 3) in Kupffer cells; there is faint diffuse staining 
of hepatocytes (grade 1). Original magnification 40×.
Photomicrograph of non-cirrhotic liver stained with Perls'  technique Figure 3
Photomicrograph of non-cirrhotic liver stained with 
Perls' technique. Liver of a 33 year-old African American 
woman who died of accidental trauma. There is heavy iron 
staining in hepatocytes (grade 3) and Kupffer cells (grade 3). 
Original magnification 40×.
Photomicrograph of cirrhotic liver stained with Perls'  technique Figure 4
Photomicrograph of cirrhotic liver stained with Perls' 
technique. Liver of a 50 year-old African American woman 
with a history of chronic alcoholism. There is a predomi-
nance of iron staining (grade 4) in hepatocytes, and promi-
nent staining of bile ductule cells. Micronodular cirrhosis and 
moderate-severe steatosis were also present. Original mag-
nification 100×.BMC Clinical Pathology 2005, 5:2 http://www.biomedcentral.com/1472-6890/5/2
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hepatocyte iron and grade 0 Kupffer cell iron (Fig. 4). Two
other subjects, neither of whom had a history of
alcoholism, also had hepatic cirrhosis. One was a 44 year-
old man with grade 4 hepatocyte iron who died of pneu-
monia (Fig. 1; Table 3). The other was a 91 year-old man
with grade 3 hepatocyte iron who died of intracranial
hemorrhage (Table 3).
Discussion
Heavy hepatocyte or Kupffer cell iron staining was
observed in 8.8% of the present subjects. This is consistent
with prevalence estimates of hepatic iron overload
reported in hospital autopsy series of African Americans
from other geographic areas [1,2]. The present subjects
were relatively young, on the average, and approximately
two-thirds died of non-natural causes. In contrast, the
subjects in previous hospital autopsy series were much
older, on the average, and most died of natural causes
[1,2]. In one hospital autopsy series, all subjects but one
were men [2]. Although there was a predominance of men
in the present study, our series included 85 women. We
observed that the percentages of men with increased hepa-
tocyte or Kupffer cell iron grades were greater than those
of women. This is in agreement with the greater mean iron
stores of African American men than women detected in
assessments of iron nutrition, and with the predominance
of men in clinical and autopsy series of African Americans
with primary iron overload [1,7,11,12]. Altogether, the
present subjects may be more representative of African
American adults in the general population than those in
hospital autopsy series [1,2], although there may be fewer
available observations regarding medical history in the
present cases than in African Americans who died in hos-
pital [1,2].
Microscopic estimation of liver iron content correlates
well with atomic absorption spectrometry measurements
in subjects in whom the histologic distribution of hepatic
iron and clinical circumstances suggest hemochromatosis,
i.e., predominance of hepatocyte iron and no apparent
explanation for iron overload [9,13-15]. These histologic
criteria were pertinent to 77% of the present subjects. On
the other hand, the relationship of iron grades and quan-
titative liver iron measurements is not well documented
in subjects in whom hepatic iron deposition occurs pre-
dominantly in macrophages, like 20% of the present sub-
jects. Hepatic iron concentrations and indices have been
used as conservative, surrogate diagnostic criteria for
primary iron overload in African Americans [1,2,7,16],
although there has been no validation of their use in such
cases. Further, some African Americans who had iron
overload demonstrated by therapeutic phlebotomy had
normal hepatic iron concentrations and indices [7,17].
Elevated hepatic iron indices have also been reported to
occur in a variety of other conditions [18-20].
Primary iron overload in African Americans is often asso-
ciated with preferential deposition of iron in macro-
phages in multiple organs [1,7,21]. In some cases, this is
associated with the inheritance of the Q248H missense
mutation of the ferroportin gene FPN1 [17,21,22]. Two of
thirteen (15.4%) African American iron overload index
patients and two of 39 (5.1%) African American control
subjects who reside in central Alabama were heterozygous
for FPN1 Q248H [21]. Nine of the present 341 (6.0%)
subjects had heavy iron staining confined to Kupffer cells.
Thus, FPN1 Q248H could account for heavy iron staining
in some of the present subjects. Other African Americans
with primary iron overload have a predominance of hepa-
tocyte iron deposition. This is consistent with hemochro-
matosis phenotypes associated with HFE  genotypes
typical of hemochromatosis in whites (HFE  C282Y/
C282Y or C282Y/H63D) [16,21], or with common types
of hemoglobinopathy or thalassemia [7,21]. Other Afri-
can Americans with primary iron overload and a predom-
inance of hepatocyte iron staining have missense
mutations of the hemojuvelin gene HJV on Ch1q [23] or
the erythroid-specific 5-aminolevulinate synthase gene
ALAS2 on ChX [24,25]. Other putative African iron over-
load alleles may account for iron overload in some cases
[26]. However, performing DNA analyses to detect muta-
tions of iron-associated genes was beyond the scope of the
present work.
Acquired disorders account for increased hepatic iron
deposition in some African Americans. In the present
study, we did not observe any subject who had heavy liver
iron staining and fibrosis or cirrhosis who did not also
have hepatic steatosis or inflammation. Chronic viral
hepatitis C occurs in approximately 1.8% of the overall
U.S. population [27], and the prevalence of chronic
hepatitis C is significantly greater in African Americans
than whites in the U.S. [27,28]. A greater proportion of
African Americans than persons of other races respond to
chronic hepatitis C infection with an increase in iron
stores, after adjustment for age, alcohol intake, gender,
menopausal status, education, body mass index, and pov-
erty index [29]. More than half of the present subjects who
had heavy iron staining had hepatic inflammation. It is
plausible that some of these had viral hepatitis C,
although this is unproven. More than one-quarter of the
present subjects who had heavy iron staining also had
hepatic steatosis. The prevalence of non-alcoholic steato-
sis and steatohepatitis is lower in African Americans than
in whites [30,31], although some risk factors for non-alco-
holic hepatic steatosis and steatohepatitis (obesity, insu-
lin resistance, and diabetes mellitus) are significantly
greater in African Americans than in whites in the U.S.
[30-32]. Taken together, these findings suggest the devel-
opment of hepatic fibrosis or cirrhosis in African Ameri-BMC Clinical Pathology 2005, 5:2 http://www.biomedcentral.com/1472-6890/5/2
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cans who have heavy hepatic iron deposition may require
the synergistic effects of hepatic steatosis or inflammation.
Iron overload sometimes develops spontaneously or after
repeated erythrocyte transfusion in African Americans
with heritable or acquired anemia, or with
myelodysplasia or acute leukemia [7,15,33-41]. Although
there were no reports of heritable or acquired anemia or
of multiple erythrocyte transfusions in the present sub-
jects, such circumstances were frequent in hospital
autopsy series of African Americans [1,2].
Three of the five present subjects with micronodular cir-
rhosis had a history of chronic alcoholism. African Amer-
icans are at greater risk than whites for developing several
alcohol-related conditions, including hepatic cirrhosis
[42,43]. In the present study, however, the prevalence of
heavy liver iron staining was similar in subjects with and
without histories of chronic alcoholism.
Conclusions
We conclude that heavy liver iron staining is common in
African American adults who were autopsied in the coro-
ner/medical examiner office. The different histologic pat-
terns of heavy liver iron staining we observed in the
present subjects are consistent with the phenotypic and
genotypic heterogeneity of primary iron overload in Afri-
can Americans [21] and with the phenotypic heterogene-
ity of iron overload of other causes [7,29,33-41].
However, the present results do not demonstrate specific
genetic or acquired causes for heavy liver iron staining in
individual subjects. Further, the present results do not
prove that the present subjects with heavy liver iron stain-
ing had systemic iron overload.
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